Girl Power 2 Cure and Rett University are excited to share the news! The first ever targeted treatment for Rett Syndrome has been approved by the FDA. Trofinetide (“DAYBUE”) will be available in April 2023. Congratulations and THANK YOU to all of our friends at Acadia...